Novel Combination Active in Large B-Cell Lymphoma, Even After CAR-T
But where mosunetuzumab/polatuzumab vedotin would fit among available options remains a question
Source: medpagetoday.com
Kami Maddocks News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Kami Maddocks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Kami Maddocks Today - Breaking & Trending Today
Pirtobrutinib Shows Potential in Heavily Pretreated Follicular Lymphoma
'Safety profile is one of the real advantages' of non-covalent BTK inhibitor, says panelist
Source: medpagetoday.com
Liso-Cel a Potential New CAR-T Option for High-Risk R/R Follicular Lymphoma
Study results show impressive efficacy, favorable safety profile in the second line
Source: medpagetoday.com
Axi-Cel Shows Durable Responses, Prolongs Overall Survival in Older LBCL Patients
Our panel discusses findings from the ZUMA-12 study and the ZUMA-7 study
Source: medpagetoday.com
Positive Results for Odronextamab in Relapsed/Refractory DLBCL
But experts aren't sure where it would fit in with currently approved bispecifics
Source: medpagetoday.com